TARKA Offer

Offer not valid in Massachusetts. Available to patients with commercial prescription insurance coverage for TARKA who meet eligibility criteria. Copay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law or by the patient’s health insurance provider. If at any time a patient begins receiving prescription drug coverage under any such federal, state, or government-funded healthcare program, patient will no longer be able to use the TARKA Savings Card and patient must call OPUS Health at 800.364.4767 to stop participation. Patients may not seek reimbursement for value received from the TARKA Savings Program from any third-party payers. Offer subject to change or discontinuance without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. Please see full Terms and Conditions.

Please answer these few questions to receive your co-pay offer.

1 Select your prescription drug insurance type:

2 Select your state:

3 Are you currently using either branded TARKA or generic trandolapril/verapamil?

Yes No

4 Which version are you currently using?

 Currently taking branded TARKA
 Currently taking generic trandolapril/verapamil
 Don’t know

TARKA® (trandolapril/verapamil hydrochloride ER tablets) Use and Important Safety Information1

USE for TARKA

  • TARKA is a prescription medicine used to treat high blood pressure.
  • TARKA combines two blood pressure medicines (trandolapril and verapamil) into one pill. TARKA is not to be used for initial treatment of high blood pressure.

IMPORTANT SAFETY INFORMATION for TARKA

  • TARKA should not be taken by women during pregnancy due to the risk of injury and even death to the developing fetus. If you become pregnant, tell your doctor right away and follow the instructions you receive about taking TARKA.
  • Do not take TARKA if you are a nursing mother.
  • Some patients taking TARKA may experience heart problems, including changes in heart rhythm. TARKA should not be taken by people with certain heart conditions or low blood pressure. If you are a diabetic patient, do not take TARKA if you are also taking aliskiren. It is very important that your doctor is aware of all current and past medical conditions, including heart problems, liver, or kidney disease.
  • Do not take TARKA if you are allergic to verapamil or an ACE inhibitor or if you are taking a medicine that is a neprilysin inhibitor (e.g., sacubitril). Do not take TARKA within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor. Ask your doctor about your medications for more information.
  • Tell your doctor about any allergic reactions to all medications. TARKA may cause serious allergic reactions or a reaction called angioedema which includes swelling of the face, body, lips, tongue, or throat. If this occurs, contact your doctor or seek emergency care right away.
  • TARKA may cause excessive low blood pressure and dizziness, especially in certain types of patients with heart failure or who are salt- or volume-depleted.
  • TARKA can cause liver problems. Notify your doctor immediately if you develop symptoms of jaundice, such as yellow coloring of the skin and eyes, while on TARKA.
  • If you have kidney disease or connective tissue disease, your doctor should do periodic blood tests, as TARKA may decrease your white blood cell count.
  • TARKA can interact with other medicines. Before and while taking TARKA, tell your doctor about all medications that you are taking, including prescription and nonprescription drugs.
  • The most common side effects include first-degree heart block, slow heart rate, bronchitis, chest pain, constipation, cough, diarrhea, dizziness, difficulty breathing, fatigue, increased liver enzymes, nausea, pain (extremities), pain (joints).

This is the most important information you should know about TARKA. For more information, talk to your doctor.

Reference: 1. TARKA [package insert]. North Chicago, IL: AbbVie Inc.

2052298-1924147